[
  {
    "ts": null,
    "headline": "Medtronic begins EMEA commercial launch of MiniMed Go Smart MDI system with Simplera sensor",
    "summary": "Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the commercial launch in Europe of the MiniMed Go™ Smart MDI system with the Simplera™ sensor. The system, which is the first and only solution to integrate data from the InPen™ smart insulin pen and the Simplera™ sensor into a single mobile app, is designed to help people who use multiple daily injections (MDI) to better control their diabetes. The launch will be rolled out gradually across Europe starting this mon",
    "url": "https://finnhub.io/api/news?id=06d708f714d5f0936e5ab1d1214deff11a2e6e8cbbf83efaf86a13a9ae2e376c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772026200,
      "headline": "Medtronic begins EMEA commercial launch of MiniMed Go Smart MDI system with Simplera sensor",
      "id": 139207592,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the commercial launch in Europe of the MiniMed Go™ Smart MDI system with the Simplera™ sensor. The system, which is the first and only solution to integrate data from the InPen™ smart insulin pen and the Simplera™ sensor into a single mobile app, is designed to help people who use multiple daily injections (MDI) to better control their diabetes. The launch will be rolled out gradually across Europe starting this mon",
      "url": "https://finnhub.io/api/news?id=06d708f714d5f0936e5ab1d1214deff11a2e6e8cbbf83efaf86a13a9ae2e376c"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic’s diabetes business MiniMed looks for $784m in US IPO",
    "summary": "The proposed IPO could see MiniMed offer 28m shares as the company looks to reach profitability independently of Medtronic.",
    "url": "https://finnhub.io/api/news?id=e92215f0918c882cb88914395b4a6e088fef3673649e5570e78a7eb774b80120",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772022688,
      "headline": "Medtronic’s diabetes business MiniMed looks for $784m in US IPO",
      "id": 139207593,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "The proposed IPO could see MiniMed offer 28m shares as the company looks to reach profitability independently of Medtronic.",
      "url": "https://finnhub.io/api/news?id=e92215f0918c882cb88914395b4a6e088fef3673649e5570e78a7eb774b80120"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic Reshapes Portfolio With MiniMed IPO And Stealth AXiS Approval",
    "summary": "Medtronic (NYSE:MDT) plans to spin off its Diabetes segment through an IPO of its subsidiary MiniMed Group, creating a standalone business focused on diabetes care. The company also received FDA clearance for its Stealth AXiS surgical system, a new platform for spine surgery. At a share price of $96.75, Medtronic has a 1 year return of 10.3% and a 3 year return of 28.9%, while the 5 year return stands at a 4.7% decline. These figures present a mixed picture for long term holders as...",
    "url": "https://finnhub.io/api/news?id=adb223a05d05b4e33b0929ce84e90b786714d23da22f8d2d8b432bc608fec193",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771985567,
      "headline": "Medtronic Reshapes Portfolio With MiniMed IPO And Stealth AXiS Approval",
      "id": 139203830,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic (NYSE:MDT) plans to spin off its Diabetes segment through an IPO of its subsidiary MiniMed Group, creating a standalone business focused on diabetes care. The company also received FDA clearance for its Stealth AXiS surgical system, a new platform for spine surgery. At a share price of $96.75, Medtronic has a 1 year return of 10.3% and a 3 year return of 28.9%, while the 5 year return stands at a 4.7% decline. These figures present a mixed picture for long term holders as...",
      "url": "https://finnhub.io/api/news?id=adb223a05d05b4e33b0929ce84e90b786714d23da22f8d2d8b432bc608fec193"
    }
  }
]